Target intelligence / Profile preview

L-asparagine (extracellular) (ASN (occasionally used for L-asparagine in general biochemistry, not as a target))

Target
ASN (occasionally used for L-asparagine in general biochemistry, not as a target)
Molecular classification
Other
01

Overview

Extracellular L-asparagine is a naturally occurring amino acid found in plasma and other body fluids. In normal physiology, it is used for protein synthesis and is taken up by cells via amino acid transporters. Certain malignancies, notably acute lymphoblastic leukemia, are unable to synthesize sufficient intracellular asparagine and depend on extracellular supplies. Drugs such as L-asparaginase exploit this vulnerability by enzymatically depleting the extracellular pool of L-asparagine, thereby starving leukemic cells and inducing apoptosis[3][4][5][6]. While extracellular L-asparagine itself is not a molecular drug target, its concentration serves as a functional biomarker and therapeutic substrate.\n\nExtracellular L-asparagine should not be listed as a canonical drug target; instead, the relevant protein target is "L-asparaginase," the enzyme used therapeutically to hydrolyze extracellular L-asparagine in certain diseases, most notably ALL[4][5][6].

Other names
L-asparagineASNasparagine
02

Mechanism of action

Enzymatic hydrolysis: L-asparaginase catalyzes conversion of extracellular L-asparagine to aspartic acid and ammonia, depriving cells (notably leukemic lymphoblasts) of asparagine necessary for protein synthesis

03

Biological functions

Precursor for protein biosynthesisSubstrate for L-asparaginase enzymesInvolved in amino acid metabolismNutrient source for cell growth
04

Disease associations

Cancer (Certain leukemias depend on extracellular L-asparagine; depletion is used therapeutically)Other disorders related to amino acid metabolism (rare)
05

Safety considerations

Depletion of circulating L-asparagine by therapeutic L-asparaginase can cause hypoalbuminemia, neurological toxicities, pancreatitis, and hypersensitivity reactionsPotential for adverse effects on normal cells reliant on extracellular asparagine
06

Interacting drugs

L-asparaginase (drugs: Elspar, Oncaspar, Erwinase—all enzymatically deplete extracellular L-asparagine)
07

Biomarkers

Extracellular L-asparagine levels (in serum/plasma) for monitoring efficacy of L-asparaginase therapyAsparagine synthetase expression in leukemic cells (predicts sensitivity/resistance to L-asparaginase)

Beyond the preview

Go deeper on L-asparagine (extracellular) (ASN (occasionally used for L-asparagine in general biochemistry, not as a target)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-asparagine (extracellular) (ASN (occasionally used for L-asparagine in general biochemistry, not as a target)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call